Laird Superfood Announces Potential Pricing for IPO

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Laird Superfood Announces Potential Pricing for IPO

© a_crotty / iStock via Getty Images

Laird Superfood has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. The company intends to price its 2.2 million shares in the range of $18 to $20 apiece, with an overallotment option for 330,000 shares. At the maximum price, the entire offering is valued up to $50.6 million. The company intends to list its shares on the New York Stock Exchange under the symbol LSF.

The underwriters for the offering are Canaccord Genuity, Craig-Hallum Capital and Roth Capital Partners.

This is an emerging consumer products platform focused on manufacturing and marketing highly differentiated plant-based and functional foods. The Laird Superfood brand is increasingly recognized and trusted by a growing number of consumers.

The core pillars of the Laird Superfood platform are currently Superfood Creamer coffee creamers, Hydrate hydration products and beverage enhancing supplements, and roasted and instant coffees, teas and hot chocolate.

[nativounit]

Although these plant-based alternatives are more for beverages, it does fill an important role in the plant-based industry. Beyond Meat and Impossible Foods already dominate the plant-based meat alternatives. While Laird Superfoods may not directly compete in these areas, it still provides an interesting play to this trend.

The company’s net sales have grown from $568,000 in 2016 to $13.1 million in 2019 and $11.1 million in the first six months of 2020, representing an annualized compound annual growth rate of approximately 185%. During the same period, gross margins have expanded from 24.8% in 2016 to 38.8% in 2019 and 31.0% in the first six months of 2020.

Laird Superfood intends to use the net proceeds from this offering for working capital and general corporate purposes, including operating expenses and capital expenditures. Additionally, the firm may use a portion of the net proceeds to acquire businesses or products to further expand its portfolio.

[recirclink id=737721][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618